Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Operating Leases: 2023-2024

Historic Operating Leases for Camp4 Therapeutics (CAMP) over the last 2 years, with Dec 2024 value amounting to $5.5 million.

  • Camp4 Therapeutics' Operating Leases fell 0.03% to $6.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 million, marking a year-over-year decrease of 0.03%. This contributed to the annual value of $5.5 million for FY2024, which is 35.28% down from last year.
  • Per Camp4 Therapeutics' latest filing, its Operating Leases stood at $5.5 million for FY2024, which was down 35.28% from $8.5 million recorded in FY2023.
  • In the past 5 years, Camp4 Therapeutics' Operating Leases registered a high of $8.5 million during FY2023, and its lowest value of $5.5 million during FY2024.
  • Over the past 2 years, Camp4 Therapeutics' median Operating Leases value was $7.0 million (recorded in 2023), while the average stood at $7.0 million.
  • Data for Camp4 Therapeutics' Operating Leases shows a maximum YoY tumbled of 35.28% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Camp4 Therapeutics' Operating Leases stood at $8.5 million in 2023, then slumped by 35.28% to $5.5 million in 2024.